Skip to main content
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mSphere
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Observation | Host-Microbe Biology

Elevated Fecal pH Indicates a Profound Change in the Breastfed Infant Gut Microbiome Due to Reduction of Bifidobacterium over the Past Century

Bethany M. Henrick, Andra A. Hutton, Michelle C. Palumbo, Giorgio Casaburi, Ryan D. Mitchell, Mark A. Underwood, Jennifer T. Smilowitz, Steven A. Frese
Julia Oh, Editor
Bethany M. Henrick
aEvolve BioSystems, Inc., Davis, California, USA
eDepartment of Food Science and Technology, University of Nebraska, Lincoln, Nebraska, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andra A. Hutton
aEvolve BioSystems, Inc., Davis, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle C. Palumbo
aEvolve BioSystems, Inc., Davis, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giorgio Casaburi
aEvolve BioSystems, Inc., Davis, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan D. Mitchell
aEvolve BioSystems, Inc., Davis, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark A. Underwood
bFoods for Health Institute, University of California, Davis, California, USA
cDepartment of Pediatrics, UC Davis Children’s Hospital, Sacramento, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer T. Smilowitz
bFoods for Health Institute, University of California, Davis, California, USA
dDepartment of Food Science and Technology, University of California, Davis, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven A. Frese
aEvolve BioSystems, Inc., Davis, California, USA
eDepartment of Food Science and Technology, University of Nebraska, Lincoln, Nebraska, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Steven A. Frese
Julia Oh
The Jackson Laboratory for Genomic Medicine
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mSphere.00041-18
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Historically, Bifidobacterium species were reported as abundant in the breastfed infant gut. However, recent studies in resource-rich countries show an increased abundance of taxa regarded as signatures of dysbiosis. It is unclear whether these differences are the product of genetics, geographic factors, or interventions such as formula feeding, antibiotics, and caesarean section. Fecal pH is strongly associated with Bifidobacterium abundance; thus, pH could be an indicator of its historical abundance. A review of 14 clinical studies published between 1926 and 2017, representing more than 312 healthy breastfed infants, demonstrated a change in fecal pH from 5.0 to 6.5 (adjusted r2 = 0.61). This trend of increasing infant fecal pH over the past century is consistent with current reported discrepancies in Bifidobacterium species abundance in the gut microbiome in resource-rich countries compared to that in historical reports. Our analysis showed that increased fecal pH and abundance of members of the families Enterobacteriaceae, Clostridiaceae, Peptostreptococcaceae, and Veillonellaceae are associated, indicating that loss of highly specialized Bifidobacterium species may result in dysbiosis, the implications of which are not yet fully elucidated. Critical assessment of interventions that restore this ecosystem, measured by key parameters such as ecosystem productivity, gut function, and long-term health, are necessary to understand the magnitude of this change in human biology over the past century.

IMPLICATIONS

There is clear evidence that the infant gut microbiome has important long-term health implications, but changing the gut microbiome is challenging. We recently observed changes in fecal pH resulting from Bifidobacterium infantis EVC001 colonization owing to this bacterium’s selective and acidic fermentation of human milk oligosaccharides (HMOs), which was associated with a reduction in taxa that are signatures of dysbiosis. Although remodeling of the gut microbiome in breastfed infants fed B. infantis EVC001 improved gut function and ecosystem productivity, questions remain about whether differences in Bifidobacterium abundance and species between resource-rich and resource-poor countries are due to host genetics, geography, medical interventions, and/or demographics. Here, we show evidence for an increase in infant fecal pH over the past century, corresponding to an observed reduction of Bifidobacterium, the keystone infant gut symbiont. This may have implications for epidemic human immunological dysfunctions as perturbations in microbiota composition can lead to chronic inflammation and immune-mediated diseases.

EARLY DESCRIPTIONS OF THE INFANT MICROBIOME

In 1913, Logan described the breastfed infant gut microbiome as being an “almost pure culture” of a Gram-positive, acidiphilic “Bacillus bifidus” (Bifidobacterium) (1). This early microscopic characterization of diet-dependent infant microbiomes is in stark contrast to modern reports from resource-rich countries of unstable and highly diverse microbiomes (2). Recent comparisons of the infant gut microbiome from genetically similar but demographically diverse backgrounds indicated that Bifidobacterium was more abundant among infants from resource-poor locations (3), consistent with infants in sub-Saharan Africa and South Asia (4, 5). These differences are also notable at the species level, in that the Bifidobacterium in the feces of infants in Gambia and Bangladesh were shown to be predominantly Bifidobacterium longum subsp. infantis (B. infantis), whereas the Bifidobacterium species in stool samples from infants in the United States and Europe consisted predominantly of B. breve and B. longum subsp. longum (B. longum) (2, 6, 7). Substantial differences in Bifidobacterium composition and abundance among populations have led to questions as to whether medical interventions (e.g., caesarean section, antibiotic use) and formula feeding, or geographic and genetic differences alone, results in these differences (2, 6).

FECAL pH IN BREASTFED INFANTS IS DRIVEN BY BIFIDOBACTERIUM ABUNDANCE

Recently, we found that breastfed infants fed B. infantis EVC001 developed a stable population of this strain and experienced substantial changes in intestinal biochemistry. Notably, fermentation of HMOs resulted in the increased production of lactate and acetate, which was markedly lower in infants who lacked populations of Bifidobacterium or were colonized by other Bifidobacterium species. This was concurrent with significantly higher fecal excretion of HMOs than that of infants fed B. infantis (7). Using data published by Frese et al. (7), we compared fecal pH measurements with bacterial taxa by using a Spearman correlation. Importantly, only one family was significantly associated with reduced fecal pH, i.e., Bifidobacteriaceae (P < 0.0004), indicating that while other bacteria can consume HMOs (e.g., Bacteroidaceae), only members of the family Bifidobacteriaceae convert them to acidic end products with a meaningful effect on fecal pH (Fig. 1). This corroborates previous findings linking infant fecal pH to Bifidobacteriaceae abundance (7, 8). This is a critical connection because although other bacteria (e.g., Lactobacillus, Clostridiaceae, Lachnospiraceae, and Ruminococcaceae) may produce organic acids during fermentation (e.g., lactate, acetate, butyrate, propionate), they were not significantly associated with the acidic fecal pH in breastfed infants. Infants colonized by B. infantis EVC001 had negligible levels of HMOs in their feces and an average fecal pH of 5.15, whereas infants lacking B. infantis had 10-fold higher levels of HMOs in their feces and a fecal pH of 5.97 (7). Further, quantitative PCR confirmed the association of low fecal pH with an increased abundance of Bifidobacterium, in agreement with another study (8).

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Correlation of bacterial families identified via 16S rRNA marker gene sequencing with fecal pH. Corresponding P values were considered statistically significant when they were ≤0.05 with false-discovery rate (FDR) correction. *, P < 0.05; **, P < 0.01; ***, P < 0.001.

INFANT FECAL pH CHANGES OVER GENERATIONS

Early 1900s reports suggest a rapid reduction in the fecal pH of breastfed infants during the first week after birth (9). Gyorgy and others identified a “bifidus factor,” whose abundance contributed to this reduction in fecal pH and an increase in Bifidobacterium in infant feces (10). This “bifidus factor” (now collectively described as HMOs), is selectively consumed by infant-associated Bifidobacterium; therefore, pH may be a reliable proxy of the breastfed infant gut microbiome. Infant fecal pH reported over the past century is independent of microbiological methodologies (e.g., microscopic examination versus 16S rRNA gene sequencing); thus, we speculated that historical reports of fecal pH could be used as an indirect measure of Bifidobacterium abundance.

Fourteen peer-reviewed studies published between 1926 and 2017 and reporting 312 measurements from healthy, breastfed infants were found and included. A least-squares linear regression model revealed a strong positive trend with a high association between the publication year and fecal pH (slope = 0.014, adjusted r2 = 0.61; Fig. 2). These data suggest that the mean fecal pH of breastfed infants has increased from about 5.0 in 1926 to 6.5 in recent years (Table 1). Given our previous finding linking fecal pH to Bifidobacterium abundance (7) and reported differences in Bifidobacterium abundance across populations today (2, 3, 6, 7), this longitudinal change is consistent with a generational loss of Bifidobacterium in developed countries, most notably among infants born after 1980.

FIG 2
  • Open in new tab
  • Download powerpoint
FIG 2

Fecal pH reported in studies along with the average, standard deviation, and numbers of samples measured (where reported) plotted by year of study publication. A linear trend (solid line) and 95% confidence interval (dashed lines) are plotted.

View this table:
  • View inline
  • View popup
TABLE 1

Studies examining the fecal pH of healthy, breastfed infants

FACTORS LEADING TO THIS CHANGE IN INFANT FECAL pH

The absence of Bifidobacterium as a keystone symbiont in infants may explain the increase in fecal pH and can be linked to unintended historical and generational consequences of certain interventions that have otherwise significantly improved infant and maternal health. First, a rapid increase in the use of human milk replacers (e.g., evaporated milk and infant formula), which lack the bacterial selectivity of human milk, beginning in the 1920s may have resulted in the inability to foster high levels of specialized infant-associated Bifidobacterium in the infant gut among nonbreastfed infants. This may also explain why B. infantis, which is highly specialized for the consumption of HMOs, is now exceptionally rare among infants in the United States and Europe, whereas B. longum and B. breve, which can access mucin glycans and plant carbohydrates (11), remain relatively abundant. Second, increased caesarean section delivery since the 1980s further limits the natural fecal-oral transfer of Bifidobacterium from mother to infant associated with vaginal delivery (12). Third, antibiotic use has become increasingly common during labor and many infant-associated species of bifidobacteria are sensitive to antibiotics (13). For example, the use of antibiotics to prevent the transmission of group B Streptococcus during delivery and the use of caesarean section as the mode of delivery are both critically important interventions in public health but can alter the acquisition of gut microbes by the infant that begins at birth (13, 14). Together, these barriers may have played a role in the loss of Bifidobacterium over time and across generations, which is reflected in a higher fecal pH.

ARE THERE HEALTH IMPLICATIONS TO THIS CHANGE?

There is clear evidence that the infant gut microbiome has important long-term health implications, and perturbations of the microbiome composition may lead to chronic inflammation (15) and immune-mediated diseases (3, 16–18). These data highlight an increase in infant intestinal dysbiosis (16). Thus, the loss of Bifidobacterium and the profound change in the gut environment, as measured by fecal pH, present a compelling explanation for the increased incidence of allergic and autoimmune diseases observed in resource-rich nations. Longitudinal analyses studies comparing the incidence of autoimmune disorders with restored Bifidobacterium populations in the infant gut microbiome are essential to establish the role of Bifidobacterium in early immune development in the infant gut.

ACKNOWLEDGMENTS

We thank the mothers and their infants for participating in the clinical trial from which these samples were collected. We also thank Cora Morgan for her assistance with technical writing and editing of the manuscript.

This work was funded by Evolve BioSystems, and we are committed to making our data, materials, and analysis methods open and available upon request, where permitted.

FOOTNOTES

    • Received January 18, 2018.
    • Accepted February 12, 2018.
  • Copyright © 2018 Henrick et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

REFERENCES

  1. 1.↵
    1. Logan WR
    . 1913. The intestinal flora of infants and young children. J Pathol 18:527–551. doi:10.1002/path.1700180154.
    OpenUrlCrossRef
  2. 2.↵
    1. Tannock GW,
    2. Lee PS,
    3. Wong KH,
    4. Lawley B
    . 2016. Why don’t all infants have bifidobacteria in their stool? Front Microbiol 7:834. doi:10.3389/fmicb.2016.00834.
    OpenUrlCrossRef
  3. 3.↵
    1. Vatanen T,
    2. Kostic AD,
    3. d’Hennezel E,
    4. Siljander H,
    5. Franzosa EA,
    6. Yassour M,
    7. Kolde R,
    8. Vlamakis H,
    9. Arthur TD,
    10. Hämäläinen A-M,
    11. Peet A,
    12. Tillmann V,
    13. Uibo R,
    14. Mokurov S,
    15. Dorshakova N,
    16. Ilonen J,
    17. Virtanen SM,
    18. Szabo SJ,
    19. Porter JA,
    20. Lähdesmäki H,
    21. Huttenhower C,
    22. Gevers D,
    23. Cullen TW,
    24. Knip M, DIABIMMUNE Study Group,
    25. Xavier RJ
    . 2016. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 165:842–853. doi:10.1016/j.cell.2016.04.007.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Zivkovic AM,
    2. German JB,
    3. Lebrilla CB,
    4. Mills DA
    . 2011. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc Natl Acad Sci U S A 108:4653–4658. doi:10.1073/pnas.1000083107.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Huda MN,
    2. Lewis Z,
    3. Kalanetra KM,
    4. Rashid M,
    5. Ahmad SM,
    6. Raqib R,
    7. Qadri F,
    8. Underwood MA,
    9. Mills DA,
    10. Stephensen CB
    . 2014. Stool microbiota and vaccine responses of infants. Pediatrics 134:e362–e372. doi:10.1542/peds.2013-3937.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Lewis ZT,
    2. Totten SM,
    3. Smilowitz JT,
    4. Popovic M,
    5. Parker E,
    6. Lemay DG,
    7. Van Tassell ML,
    8. Miller MJ,
    9. Jin YS,
    10. German JB,
    11. Lebrilla CB,
    12. Mills DA
    . 2015. Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants. Microbiome 3:13. doi:10.1186/s40168-015-0071-z.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Frese SA,
    2. Hutton AA,
    3. Contreras LN,
    4. Shaw CA,
    5. Palumbo MC,
    6. Casaburi G,
    7. Xu G,
    8. Davis JCC,
    9. Lebrilla CB,
    10. Henrick BM,
    11. Freeman SL,
    12. Barile D,
    13. German JB,
    14. Mills DA,
    15. Smilowitz JT,
    16. Underwood MA,
    17. Krajmalnik-Brown R
    . 2017. Persistence of supplemented Bifidobacterium longum subsp. infantis EVC001 in breastfed infants. mSphere 2:e00501-17. doi:10.1128/mSphere.00501-17.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Matsuki T,
    2. Yahagi K,
    3. Mori H,
    4. Matsumoto H,
    5. Hara T,
    6. Tajima S,
    7. Ogawa E,
    8. Kodama H,
    9. Yamamoto K,
    10. Yamada T,
    11. Matsumoto S,
    12. Kurokawa K
    . 2016. A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nat Commun 7:11939. doi:10.1038/ncomms11939.
    OpenUrlCrossRef
  9. 9.↵
    1. Norton RC,
    2. Shohl AT
    . 1926. The hydrogen ion concentration of the stools of the new-born infants. Am J Dis Child 32:183–191.
    OpenUrlCrossRef
  10. 10.↵
    1. Gyorgy P,
    2. Norris RF,
    3. Rose CS
    . 1954. A variant of Lactobacillus bifidus requiring a special growth factor. Arch Biochem Biophys 48:193–201. doi:10.1016/0003-9861(54)90323-9.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Pokusaeva K,
    2. Fitzgerald GF,
    3. van Sinderen D
    . 2011. Carbohydrate metabolism in bifidobacteria. Genes Nutr 6:285–306. doi:10.1007/s12263-010-0206-6.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Betrán AP,
    2. Ye J,
    3. Moller AB,
    4. Zhang J,
    5. Gülmezoglu AM,
    6. Torloni MR
    . 2016. The increasing trend in caesarean section rates: global, regional and national estimates: 1990–2014. PLoS One 11:e0148343-12. doi:10.1371/journal.pone.0148343.
    OpenUrlCrossRef
  13. 13.↵
    1. Duranti S,
    2. Lugli GA,
    3. Mancabelli L,
    4. Turroni F,
    5. Milani C,
    6. Mangifesta M,
    7. Ferrario C,
    8. Anzalone R,
    9. Viappiani A,
    10. van Sinderen D,
    11. Ventura M
    . 2017. Prevalence of antibiotic resistance genes among human gut-derived bifidobacteria. Appl Environ Microbiol 83:e02894-16. doi:10.1128/AEM.02894-16.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Stearns JC,
    2. Simioni J,
    3. Gunn E,
    4. McDonald H,
    5. Holloway AC,
    6. Thabane L,
    7. Mousseau A,
    8. Schertzer JD,
    9. Ratcliffe EM,
    10. Rossi L,
    11. Surette MG,
    12. Morrison KM,
    13. Hutton EK
    . 2017. Intrapartum antibiotics for GBS prophylaxis alter colonization patterns in the early infant gut microbiome of low risk infants. Sci Rep 7:16527. doi:10.1038/s41598-017-16606-9.
    OpenUrlCrossRef
  15. 15.↵
    1. Sommer F,
    2. Bäckhed F
    . 2013. The gut microbiota—masters of host development and physiology. Nat Rev Microbiol 11:227–238. doi:10.1038/nrmicro2974.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Knip M,
    2. Honkanen J
    . 2017. Modulation of type 1 diabetes risk by the intestinal microbiome. Curr Diab Rep 17:105. doi:10.1007/s11892-017-0933-9.
    OpenUrlCrossRef
  17. 17.↵
    1. Knip M,
    2. Siljander H
    . 2016. The role of the intestinal microbiota in type 1 diabetes mellitus. Nat Rev Endocrinol 12:154–167. doi:10.1038/nrendo.2015.218.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Arrieta MC,
    2. Stiemsma LT,
    3. Dimitriu PA,
    4. Thorson L,
    5. Russell S,
    6. Yurist-Doutsch S,
    7. Kuzeljevic B,
    8. Gold MJ,
    9. Britton HM,
    10. Lefebvre DL,
    11. Subbarao P,
    12. Mandhane P,
    13. Becker A,
    14. McNagny KM,
    15. Sears MR,
    16. Kollmann T, CHILD Study,
    17. Mohn WW,
    18. Turvey SE,
    19. Finlay BB
    . 2015. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med 7:307ra152. doi:10.1126/scitranslmed.aab2271.
    OpenUrlAbstract/FREE Full Text
  19. 19.
    1. Eitel H
    . 1917. Die wahre Reaktion der Stühle gesunder Säuglinge bei verschiedener Ernährung. Z Kinderheilkd 16:13–62. doi:10.1007/BF02222668.
    OpenUrlCrossRef
  20. 20.
    1. Freudenberg E,
    2. Heller O
    . 1921. Über Darmgärung II. Über den Einfluss von Eiweiss und Kalk auf die Gärung. Jahresber Kinderheilkd 95:314.
    OpenUrl
  21. 21.
    1. Tisdall FF
    . 1924. Studies of the acidity (hydrogen ion concentration) of infants’ stools. Arch Pediatr Adolesc Med 27:312–331. doi:10.1001/archpedi.1924.01920100017003.
    OpenUrlCrossRef
  22. 22.
    1. Uldall C
    . 1942. Comparative studies on feces of healthy breast, bottle and spoon-fed infants. Acta Paediatr 29:339–366. doi:10.1111/j.1651-2227.1942.tb16393.x.
    OpenUrlCrossRef
  23. 23.
    1. Barbero GJ,
    2. Runge G,
    3. Fischer D,
    4. Crawford MN,
    5. Torres FE,
    6. Gyorgy P
    . 1952. Investigations on the bacterial flora, pH, and sugar content in the intestinal tract of infants. J Pediatr 40:152–163. doi:10.1016/S0022-3476(52)80176-3.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.
    1. Pratt AG,
    2. Read WT
    . 1955. Influence of type of feeding on pH of stool, pH of skin, and incidence of perianal dermatitis in the newborn infant. J Pediatr 46:539–543. doi:10.1016/S0022-3476(55)80259-4.
    OpenUrlCrossRefPubMed
  25. 25.
    1. Nagai T
    . 1960. Clinical and experimental studies of ethyl-N-acetyl-d-glucosamine as bifidus factor. Pediatr Int 3:83–102. doi:10.1111/j.1442-200X.1960.tb01617.x.
    OpenUrlCrossRef
  26. 26.
    1. Bullen CL,
    2. Willis AT
    . 1971. Resistance of the breast-fed infant to gastroenteritis. Br Med J iii:338–343.
    OpenUrl
  27. 27.
    1. Bullen CL,
    2. Tearle PV,
    3. Stewart MG
    . 1977. The effect of “humanised” milks and supplemented breast feeding on the faecal flora of infants. J Med Microbiol 10:403–413. doi:10.1099/00222615-10-4-403.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.
    1. Simhon A,
    2. Douglas JR,
    3. Drasar BS,
    4. Soothill JF
    . 1982. Effect of feeding on infants’ faecal flora. Arch Dis Child 57:54–58.
    OpenUrlPubMed
  29. 29.
    1. Balmer SE,
    2. Wharton BA
    . 1989. Diet and faecal flora in the newborn: breast milk and infant formula. Arch Dis Child 64:1672–1677. doi:10.1136/adc.64.12.1672.
    OpenUrlAbstract/FREE Full Text
  30. 30.
    1. Ogawa K,
    2. Ben RA,
    3. Pons S,
    4. de Paolo MI,
    5. Bustos Fernández L
    . 1992. Volatile fatty acids, lactic acid, and pH in the stools of breast-fed and bottle-fed infants. J Pediatr Gastroenterol Nutr 15:248–252. doi:10.1097/00005176-199210000-00004.
    OpenUrlCrossRefPubMed
  31. 31.
    1. Knol J,
    2. Scholtens P,
    3. Kafka C,
    4. Steenbakkers J,
    5. Gro S,
    6. Helm K,
    7. Klarczyk M,
    8. Schöpfer H,
    9. Böckler HM,
    10. Wells J
    . 2005. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr 40:36–42. doi:10.1097/00005176-200501000-00007.
    OpenUrlCrossRefPubMed
  32. 32.
    1. Mohan R,
    2. Koebnick C,
    3. Schildt J,
    4. Mueller M,
    5. Radke M,
    6. Blaut M
    . 2008. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr Res 64:418–422. doi:10.1203/PDR.0b013e318181b7fa.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.
    1. Holscher HD,
    2. Faust KL,
    3. Czerkies LA,
    4. Litov R,
    5. Ziegler EE,
    6. Lessin H,
    7. Hatch T,
    8. Sun S,
    9. Tappenden KA
    . 2012. Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial. JPEN J Parenter Enteral Nutr 36:95S–105S. doi:10.1177/0148607111430087.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Elevated Fecal pH Indicates a Profound Change in the Breastfed Infant Gut Microbiome Due to Reduction of Bifidobacterium over the Past Century
Bethany M. Henrick, Andra A. Hutton, Michelle C. Palumbo, Giorgio Casaburi, Ryan D. Mitchell, Mark A. Underwood, Jennifer T. Smilowitz, Steven A. Frese
mSphere Mar 2018, 3 (2) e00041-18; DOI: 10.1128/mSphere.00041-18

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print
Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mSphere article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Elevated Fecal pH Indicates a Profound Change in the Breastfed Infant Gut Microbiome Due to Reduction of Bifidobacterium over the Past Century
(Your Name) has forwarded a page to you from mSphere
(Your Name) thought you would be interested in this article in mSphere.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Elevated Fecal pH Indicates a Profound Change in the Breastfed Infant Gut Microbiome Due to Reduction of Bifidobacterium over the Past Century
Bethany M. Henrick, Andra A. Hutton, Michelle C. Palumbo, Giorgio Casaburi, Ryan D. Mitchell, Mark A. Underwood, Jennifer T. Smilowitz, Steven A. Frese
mSphere Mar 2018, 3 (2) e00041-18; DOI: 10.1128/mSphere.00041-18
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • IMPLICATIONS
    • EARLY DESCRIPTIONS OF THE INFANT MICROBIOME
    • FECAL pH IN BREASTFED INFANTS IS DRIVEN BY BIFIDOBACTERIUM ABUNDANCE
    • INFANT FECAL pH CHANGES OVER GENERATIONS
    • FACTORS LEADING TO THIS CHANGE IN INFANT FECAL pH
    • ARE THERE HEALTH IMPLICATIONS TO THIS CHANGE?
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Bifidobacterium
biochemistry
infant microbiome
microbiome

Related Articles

Cited By...

About

  • About mSphere
  • Board of Editors
  • Policies
  • For Reviewers
  • For the Media
  • Embargo Policy
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Types of Articles
  • Getting Started
  • Ethics
  • Contact Us

Follow #mSphereJ

@ASMicrobiology

       

 

Website feedback

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2379-5042